Antiviral Agents – Talk Bio

Actionable Insights Powered by AI

Zelicapavir Shows Promising Antiviral Effect in Pediatric RSV Study

5 months ago talkbio0Tagged Antiviral Agents, Pediatric brand name, Phase 2 Clinical Trials, Respiratory syncytial virus, Zelicapavir

Zelicapavir, RSV, Antiviral, Pediatric, Phase 2 Study, Respiratory Syncytial Virus

Johnson & Johnson Halts Phase II Dengue Study Amid Shift in R&D Priorities

7 months ago talkbio0Tagged Antiviral Agents, Communicable Diseases, Dengue Study, Johnson and Johnson, mosnodenvir, Phase II, Priorities, R&D

Johnson & Johnson, Dengue Study, Phase II, Antiviral Drug, Mosnodenvir, Infectious Diseases, R&D Priorities

Mpox Outbreak in Africa: Siga’s Tpoxx Antiviral Falls Short in Congo Study

8 months ago talkbio0Tagged 3-(2-methoxyphenyl)-5-methoxy-1,3,4-oxadiazol-2(3H)-one, Africa, Antiviral Agents, Clinical Research, Congo, Disease Outbreaks, Tpoxx

mpox, Tpoxx, antiviral, Congo study, Africa outbreak, Siga, tecovirimat